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Abstract. Previous studies have shown anti-inflammatory
potential of alkaline extract of the leaves of Sasa
senanensis Rehder (SE). The aim of the present study was
to clarity the molecular entity of SE, using various
fractionation methods. SE inhibited the production of nitric
oxide (NO), but not tumour necrosis factor-α by
lipopolysaccharide (LPS)-stimulated mouse macrophage-
like cells. Lignin carbohydrate complex prepared from SE
inhibited the NO production to a comparable extent with
SE, whereas chlorophyllin was more active. On successive
extraction with organic solvents, nearly 90% of SE
components, including chlorophyllin, were recovered from
the aqueous layer. Anti-HIV activity of SE was comparable
with that of lignin-carbohydrate complex, and much higher
than that of chlorophyllin and n-butanol extract fractions.
The CYP3A inhibitory activity of SE was significantly lower
than that of grapefruit juice and chlorophyllin. Oral
administration of SE slightly reduced the number of oral
bacteria. When SE was applied to HPLC, nearly 70% of SE
components were eluted as a single peak. These data
suggest that multiple components of SE may be associated
with each other in the native state or after extraction with
alkaline solution.
Alkaline extract of the leaves of Sasa senanensis Rehder or
Sasa albo-marginata Makino et Shibata (SE) (SASA-
Health®), as an over the counter drug, is recognized as being
effective in treating fatigue, low appetite, halitosis, body odour
and stomatitis. However, there is no scientific evidence that
demonstrates these phenomena. SE has been reported to show
antiseptic (1), membrane stabilising (2), anti-inflammatory and
phagocytic (3), radical scavenging (4), antibacterial, anti-viral
and radical scavenging activities (5). It was recently reported
that SE inhibited nitric oxide (NO) and prostaglandin E2
(PGE2) production by lipopolysaccharide (LPS)-activated
mouse macrophage-like cells (RAW264.7) via inhibition of
inducible NO synthase and cyclooxygenase-2 expression at
both protein and mRNA levels (6).
In order to further expand the anti-inflammatory spectrum
of SE, we first investigated whether SE inhibits the
production of tumour necrosis factor-α (TNF-α), a pro-
inflammatory cytokine, by LPS-activated mouse macro-
phage-like cells (RAW264.7, J774.1). Since chlorophyllin, a
modifier of genotoxic effects (7), is present in SE at 0.25-
0.26% (w/w) (8), it was also investigated whether chloro-
phyllin efficiently inhibits NO production by activated
macrophages. It was previously reported that SE showed
potent anti-HIV activity, comparable to lignin-carbohydrate
complex from other species (5). Therefore, the possible anti-
HIV activity of lignin-carbohydrate complex prepared from
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SE was investigated for the first time. There is no study to
date that has investigated the effect of SE on CYP3A
activity. It was hypothesized that if SE inhibits CYP3A
activity, it may enhance the bio-availability of drugs
(especially, CYP3A substrates) that are administered together
with SE. Therefore, whether SE actually inhibits CYP3A
activity, using grapefruit juice as a positive control (9), was
investigated. Based on in vitro antiviral and antibacterial
activity (5), there is a possibility that oral administration of
SE may reduce the number of bacterial in the oral cavity.
Therefore this possibility was investigated in this study,
using real-time PCR.
Materials and Methods
Materials. The following chemicals and reagents were obtained
from the indicated companies: Dulbecco’s modified Eagle’s medium
(DMEM) (Gibco BRL, Grand Island, NY, USA); fetal bovine serum
(FBS) (JRH Bioscience, KS, USA); LPS from Escherichia coli
(Serotype 0111:B4), 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-
tetrazolium bromide (MTT) (Sigma Chem Co., St. Louis, MO,
USA); testosterone (Nacalai Tesque, Inc, Kyoto, Japan); 6β-
hydroxytestosterone (Daiichi Pure Chemicals Co Ltd, Tokyo,
Japan); corticosterone (internal standard), acetonitrile of HPLC
grade, dimethyl sulfoxide (DMSO), all other chemicals of reagent
grade (Wako Pure Chem Ind., Osaka, Japan). 
SE was prepared and supplied by Daiwa Biological Research
Institute Co, Ltd, Kawasaki, Kanagawa, Japan. Lyophilisation and
measurement of the dry weight of SE showed that it contained
58.2±0.96 mg solid materials/ml (5).
Preparation of lignin-carbohydrate complex and polysaccharide
fractions. SE was centrifuged at 14,400×g for10 min at 15˚C to
remove the insoluble materials. When the pH was lowered to 5 by
drop-wise addition of acetic acid, fraction (Fr) I was precipitated.
Fr I was dissolved in 1.39% NaHCO3 or 1% NaOH, and the
insoluble materials were removed. Addition of acetic acid to the
supernatant precipitated Frs II and III, respectively. An equal
amount of ethanol was added to the supernatant cleared of Fr I in
order to precipitate polysaccharide fraction (Fr IV). All fractions
were dialysed against water, and lyophilised (Figure 1).
Stepwise extraction of SE with organic solvents. SE (1164 mg) was
extracted three times with 1 ml of n-hexane, and the n-hexane layer
was concentrated under vacuum. The aqueous layer was extracted
three times with 1 ml of Et2O. The obtained aqueous layer was further
extracted three times with AcOEt, and then n-BuOH (Table I). 
For large scale fractionation, 254 ml of SE was fractionated into
n-hexane (26.2 mg), Et2O (135.2 mg), AcOEt (94.6 mg), n-BuOH
(511.6 mg) and aqueous fractions (28486.2 mg). n-BuOH fraction
(500 mg) was applied on a silica gel column and then eluted with
CHCl3 (Fr. 1: 3.3 mg), CHCl3:MeOH (49:1) (Fr. 2: 53.6 mg),
CHCl3: MeOH (19:1) (Fr. 3: 83.7 mg), CHCl3:MeOH (9:1) (Fr. 4:
14.3 mg), CHCl3:MeOH (9:1) (Fr. 5: 45.4 mg), CHCl3:MeOH (4:1)
(Fr. 6: 58.9 mg), and MeOH (Fr. 7: 145.0 mg). 
HPLC analysis of crude SE extract. SE (5 μl) was applied to an HPLC
column: Develosil RPAQUEOUS (C-30) and eluted, and analysed for
70 min, using the following conditions: Mobile phase: A (0.1 % TFA
in H2O), B (CH3CN), gradient (0-10 min: B10%, 10-50 min: B10%-
B50%, 50-70 min: B50%); flow rate: 1.0 ml/min; detection: UV 210-
400 nm; column temperature: 40˚C.
Cell culture. RAW264.7 cells (10), J774.1 cells (11), human oral
normal cells (gingival fibroblast HGF, pulp cell HPC, periodontal
ligament fibroblast HPLF) (5) and human oral squamous cell
carcinoma cell lines (HSC-2, HSC-3, HSC-4) (Riken Cell Bank,
Ibaraki) (5) were cultured in DMEM supplemented with 10% heat-
inactivated FBS under a humidified 5% CO2 atmosphere. Human
promyelocytic leukemia cell line HL-60 and human T-cell leukemia
virus I (HTLV-I)-bearing CD4 positive human T cell line, MT-4 were
cultured in suspension in RPMI-1640 medium supplemented with 10%
heat-inactivated FBS, as described previously (5).
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Figure 1. Fractionation of SE. Yield of fractions (Frs) I and II represents
the mean±SD from three independent experiments.
Table I. Distribution of chlorophyllin and components that inhibited the
NO production by macrophages into fractions separated by successive
organic solvent extractions.
Yield Volume Conc. CC50 IC50 SI
mg(%) ml mg/ml mg/ml mg/ml CC50/IC50
Initial 1164 (100) 20.0 58.2 13.6184 1.597 8.53
n-Hexane 7.4 (0.6) 0.4 18.5 0.1715 0.0387 4.43
Et2O 6.2 (0.5) 0.4 15.5 0.1253 0.0245 5.00
AcOEt 13.2 (1.1) 0.4 33.0 0.2478 0.03193 7.76
n-BuOH 67.6 (5.8) 0.8 84.5 1.2288 0.1068 11.51
H2O 943 (81.0) 20.0 47.2 22.8598 2.12 10.78
Total 1037.4 (89.1)
Determination of viable cell number. RAW264.7 or J774.1 were
inoculated at 1.5×106/ml (100 μl) in a 96-microwell plate (Becton
Dickinson, Labware, NJ, USA) and incubated for 1-2 hours. Near-
adherent cells were replaced with fresh culture medium and treated
for 24 hours with the indicated concentrations of SE in phenol red-
free DMEM supplemented with 10% FBS in the presence or
absence of LPS (0.1 μg/ml). Viable cell number was then
determined by the MTT method. In brief, cells were incubated for
30 minutes with 0.2 mg/ml of MTT. After removal of the medium,
the cells were lysed with DMSO, and the absorbance at 540 nm was
recorded using microplate reader (12, 13).
Near-confluent human normal (HGF, HPC, HPLF) and tumour
cells (HSC-2, HSC-3, HSC-4) were treated for 48 hours with various
concentrations of test samples, and the relative viable cell number of
adherent cells was then determined by the MTT method. The viable
cell number of HL-60 cells was determined by hemocytometer after
staining with trypan blue. The 50% cytotoxic concentration (CC50)
was determined from the dose-response curve. The tumour-specificity
index (TS) was measured by the following equation: TS=
[CC50(HGF)+CC50(HPC)+CC50(HPLF)]/[CC50(HSC-2)+CC50(HSC-
3)+CC50(HSC-4)+CC50(HL-60)]×(4/3).
Assay for NO and TNF-α production. RAW264.7 or J774.1 cells
were inoculated at 1.5×106/ml (100 μl) in a 96-microwell plate and
incubated for 1-2 hours. Near confluent cells were treated for 24
hours without or with the indicated concentrations of SE (0.9-50%)
in phenol red-free DMEM supplemented with 10% FBS in the
presence or absence of LPS (0.1 μg/ml). The NO and TNF-α
released into the culture medium was quantified as follows.
NO was determined by Griess reagent, using the standard curve of
NO2–. To eliminate the interaction between sample and Griess reagent,
the NO concentration was also measured in the culture medium
without the cells, and this value was subtracted from that obtained with
the cells. Then the concentration that inhibited the LPS-stimulated NO
production by 50% (50% inhibitory concentration: IC50) was
determined from the dose-response curve (14). The efficacy of inhi-
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Figure 2. Effect of SE on NO (A) and TNF-α (B) production by mouse macrophage-like cells (J774.1, RAW264.7). J774.1 (A, D, F) or RAW264.7
cells (B, E, G) were incubated for 24 hours with the indicated concentrations of SE in the absence (open symbol) or presence (closed symbols) of
100 ng/ml LPS, and the viable cell number (circle), NO (A-E) or TNF-α (F-H) (bar) was determined. Since SE has color that interferes the NO
determination, the data of without cell (C) was subtracted from A and B to yield D and E. Since SE itself did not affect the TNF-α determination
(H), data of F and G were used without subtraction of data of H. Each value represents mean of duplicate determinations.
bition of NO production was evaluated by the selectivity index (SI),
which was calculated using the following equation: SI=CC50/IC50.
The TNF released into culture medium was determined by ELISA
(Quantikine ELISA kit, R&D systems, Minneapolis, MN, USA).
Assay for anti-/HIV-IIVB HIV activity. MT-4 cells were infected with
HIV
-1IIIB at a multiplicity of infection (m.o.i.) of 0.01. HIV- or
mock-infected (control) MT-4 cells were incubated for 5 days with
various concentrations of test samples, and the relative viable cell
number was determined by MTT assay. The 50% cytotoxic
concentration (CC50) and 50% effective concentration (EC50) were
determined from the dose-response curve with mock-infected or
HIV-infected cells, respectively (15). All the data represent the mean
values of triplicate measurements. The anti-HIV activity was
evaluated by selectivity index (SI), which was calculated by the
following equation: SI=CC50/EC50
Assay for cytochrome P-450 3A (CYP3A) activity. CYP3A activity
was assayed by the ability to oxidise 6β-position of testosterone,
using rat liver microsome fraction (16). Testosterone (0.2 mM) was
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Table II. Anti-HIV activity and anti-inflammatory activity of SE components.
Anti-HIV activity Anti-inflammatory activity
CC50 (μg/ml) EC50 (μg/ml) SI CC50 (μg/ml) IC50 (μg/ml) SI
SE 638±12 18±3.1 36 4132±1164 396±87 10.3
Lignin Fr I (acid precipitation) 591 16 37 >5000 455±51 >11.3
Lignin Fr II (acid precipitation×2) 566 9.8 58 >5000 889±92 >5.8
Lignin Fr III (acid precitation×2) 735 12 62
Polysaccharide Fr IV >1000 >1000 ≤1 >5000 >5000 ≤1.0
Lignin Fr I (acid precipitation) 321±36 10±1.4 32
Lignin Fr II (acid precipitation×2 ) 246±3.3 9.3±0.8 27
n-BuOH extract Fr 0 91 >800 <1
n-BuOH extract Fr 1 325 >400 <1
n-BuOH extract Fr 2 71 >800 <1
n-BuOH extract Fr 3 86 >800 <1
n-BuOH extract Fr 4 180 >800 <1
n-BuOH extract Fr 5 126 >800 <1
n-BuOH extract Fr 6 397 >800 <1
n-BuOH extract Fr 7 429 59 7
Chlorophyllin (μg/ml) 97 18 5.4 36.4±1.7 1.5±0.22 25.1
Chlorophyll (μg/ml) 41.0±9.8 11.7±1.3 3.5
Lignin-carbohydrate complexes (Frs I, II, III) and polysaccharide (Fr IV) were prepared as described in Figure 1. n-BuOH fractions were separated
as described in the Materials and Methods. Anti-inflammatory activity was assayed by the ability to inhibit the NO production by LPS-stimulated
RAW264.7 cells, as described in Figure 2.
Table III. Tumour-specificity of n-BuOH extracts of SE.
CC50 (μg/ml)
Human tumor cell lines Human normal oral cells
Fr HSC-2 HSC-3 HSC-4 HL-60 HGF HPC HPLF TS
0 201±41 340±3 184±34 77±8 331±7 332±8 338±3 1.7
1 384±36 >400 346±22 178±7 >400 >400 >400 ><1.2
2 64±13 122±1 75±4 35±2 143±11 105±21 152±1 1.8
3 89±1 151±7 80±2 37±1 176±24 205±30 208±4 2.2
4 288±2 >400 243±14 70±8 >400 >400 >400 >1.6
5 258±6 >400 317±3 86±1 >400 >400 >400 >1.5
6 327±2 >400 303±3 141±19 >400 >400 >400 >1.4
7 >400 >400 >400 309±5 >400 >400 >400 >1.1
Each value represents the mean±SD of triplicate determinations.
incubated for 5 min at 37˚C in 0.1 M sodium phosphate buffer (pH
7.4) containing 1 mM NADPH and rat microsome. Ten-volume of
corticosterone-acetonitrile solution (2 μg/ml) was then added to the
reaction mixture as an internal marker. After 20 s mixing, the
mixture was centrifuged at 16,000 ×g for 5 min at 4˚C, and 6β-
hydroxytestosterone in the obtained supernatant was determined
using an LC/ESI/MS system (Shimadzu LCMS-2010EV). Reverse
phase Capcell Pak MGII-ODS column (2.0 mm×15 cm; particle
size: 5 μm) (Shiseido Co, Ltd, Tokyo, Japan) was used as solid
phase. H2O/acetonitrile was used as mobile phase (flow rate: 0.2
ml/min). The concentration of acetonitrile in mobile phase was 10-
100% (0-8 min) and 100% (8-20 min). For mass spectrometry, anion
mode (interface voltage: 4.5 kV, detector voltage: 1.5 kV, heat block
temperature: 200˚C, CDL temperature: 250˚C) was used to detect
the molecular ion (m/z: 303.2 and 345.2) of 6β-hydroxytestosterone
and corticosterone. Nitrogen (flow rate: 1.5 l/min) was used as
nebuliser gas. 6β-Hydroxytestosterone standard solution (1-60 μM)
was used to determine the standard curve.
Determination of oral bacterial DNA. Three healthy male volunteers
(A, B, C) had taken 10 ml of 10% (v/v) SE (diluted 10-fold with water)
three times a day, within 30 min after each meal, retaining it for
approximately 1 min in the oral cavity and then swallowing. Bacteria
from saliva and tongue coat were collected just before the lunch at day
1, 3, 7, 14, 21, 28 after the start of SE administration. As a control,
bacteria collection was performed 5 times (once a day for 5 days)
before SE administration. Bacteria were collected from the periodontal
pocket before SE administration, and 7 days after SE administration.
The number of bacteria was then measured by real-time PCR,
according to the guidelines of the intramural Ethics Committee
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Figure 3. Chlorophyllin inhibited NO production by activated macrophages more potently than did chlorophyll. RAW264.7 cells were incubated for 24
hours with the indicated concentrations of chlorophyllin (A) or chlorophyll (B) in the absence (no color) or presence (colored) of 100 ng/ml LPS, and
viable cell number (circle) and NO in the culture medium (bar) were determined. Each value represents the mean±SD of triplicate determinations.
Figure 4. Inhibition of CYP3A activity by SE, grapefruit juice and chlorophyllin. CYP3A activity was measured by hydroxylase activity of 6β-position
of testosterone. Each value represents the mean±SD of triplicate determinations.
(approved as No A0901), after obtaining the informed consents from
three healthy volunteers (A, B, C). Bacteria in saliva (1 ml), the tongue
coat (collected by scraping with loop) and the periodontal pocket
[corrected by sterile paper point (Johnson & Johnson, New Brunswick,
NJ, USA)] were washed three times with 1 ml PBS(–).
DNA was extracted from these three samples using Ultra Clean
Microbial DNA Isolation Kit (MO BIO Laboratories, Inc, Carlsbad,
CA, USA). After adjusting the DNA concentration to 2 ng/5 μl, real-
time PCR was performed with LightCyclerR 480 (Roche Molecular
Biochemicals, Mannheim, Germany), using specific primers (5’-3’)
(40 μM): Total bacteria (Universal) (forward: TCCTACGGGA
GGCACAGT; reverse: GGACTACCAGGGTATCTAATCCTGTT;
Taqman probe: CGTATTACCGCGGCTGCTGGCAC), Fusobacterium
(F. nucleatum, F . periodonticum, F. alocis, F. simiae) (forward:
AAGCGCGTCTAGGTGGTTATGT; Reverse: TGTAGTTCCGCTT
ACCTCTCCAG; Taqman probe: CAACGCAATACAGAGTTGA
GCCCTGCATT), Prevotella (forward: CCAGCCAAGTAGCGT
GCA; reverse: TGGACCTTCCGTATTACCGC; Taqman probe:
AATAAGGACCGGCTAATTCCGTGCCAG), Porphyromonas gingi-
valis (forward: TCGGTAAGTCAGCGGTGAAAC; reverse: GCAAG
CTGCCTTCGCAAT; Taqman probe: CTCAACGTTCAGCCTGCC
GTTGAAA). Concentration of Taqman fluorescent probe was 11 μM
(Universal, Fusobacterium), 13 μM (Prevotella) and 14 μM (P.
gingivalis). 
Reaction mixture (20 μl) contains DNA solution (5 μl), Light
CyclerR 480 Probe Master (10 μl), Taqman probe (0.2 μl), forward
primer (0.2 μl), reverse primer (0.2 μl), dH2O (4.4 μl). Amplification
program: Initial denaturation (95˚C, 5 min), amplification reaction
(95˚C, 10 min), annealing elongation reaction (45 cycles of 60˚C, 30 s
and 72˚C, 1 s), heating up to 95˚C and then cooled down to 50˚C.
Standard curve of DNA of each bacterial was produced, using 10-106-
fold diluted sample [P. intermedia (ATCC 25611), P. gingivalis (ATCC
33277), F. nucleatum (ATCC 31647)]. 
Results
Effect of SE on NO and TNF-α production by mouse
macrophage-like cells. Colorimetric determination of NO by
the Griess method is considerably affected by the colour of
SE. It was therefore essential to subtract the absorbance
value derived from SE (Figure 2C). When this value was
in vivo 24: 735-744 (2010)
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Figure 5. Changes in the number of bacteria in saliva, tongue coat and periodontal pocket after administration of SE to three healthy males A (53
years old), B (57 years old) and C (33 years old). (a-g) mean the location where sample was collected: (a) the upper left permanent second molar,
(b) the lower right permanent first premolar, (c) the lower left permanent first premolar, (d) the upper left permanent first molar, (e) the lower left
permanent third molar, (f) the upper left permanent second molar, (g) the lower left permanent first molar. White bars, number of bacteria before
SE administration; gray bars, number of bacteria 7 days after SE administration.
subtracted from each point (Figure 2A B), it was found that
SE did not induce NO production, but rather inhibited the
NO production induced by LPS (100 ng/ml) in both J774.1
and RAW264.7 cells (Figure 2D, E) (SI=10.3) (Table II).
Similar results were obtained when SE was autoclaved
before being added to the cells (data not shown).
On the contrary, it was found that SE itself did not
interfere with the TNF-α determination (Figure 2H),
indicating that it is not necessary to subtract the value of SE
alone. SE slightly enhanced the TNF-α production at lower
concentrations, whereas it inhibited the TNF-α production at
higher concentrations, due to its cytotoxicity (Figure 2F, G).
Similar results were obtained when autoclaved SE was used
(data not shown).
Effect of SE components on NO production. Commercially
available chlorophyllin inhibited NO production by LPS-
activated RAW264.7 cells (SI=25.1), whereas chlorophyll was
much less active (SI=3.5) (Figure 3, Table II). When SE was
extracted with various organic solvents, 90.8% (corrected for
the recovery) of SE components were recovered from the
aqueous layer, followed by n-BuOH (6.5%), AcOEt (1.2%),
Et2O (0.6%) and n-hexane layers (0.7%) (Table I). It was
unexpected that chlorophyllin was distributed into these
fractions. The majority of the activity that inhibited NO
production by LPS-activated RAW264.7 cells was recovered
from the water (SI=10.78) and n-BuOH layers (SI=11.51)
(Table I). SE has approximately 20% (w/w) lignin-carbohydrate
complex (Figure 1). Lignin carbohydrate complexes (Frs. I-III)
inhibited the NO production comparably (SI≥5.8->11.3),
whereas polysaccharide fraction (Fr. IV) was inactive (SI≥<1.0)
(Table II). These data suggest that chlorophyllin in SE may be
associated with hydrophilic substances.
Anti-HIV activity of lignin-carbohydrate complex in SE. SE
showed potent anti-HIV activity (SI=36), comparable with
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Figure 6. HPLC analysis of crude SE extract. A: Autoscale chromatogram; B: spectral index
lignin carbohydrate complexes prepared without (Fr. I)
(SI=32-37) or with the repeated cycle of acid precipitation
and solubilisation (Frs. II, III) (SI=27-62) (Table II). On the
contrary, polysaccharide fraction (Fr IV) was inactive (SI≥1).
n-BuOH fraction (no. 0) and its seven subfractions (No 1-7),
separated by silica gel column chromatography, showed
essentially no anti-HIV activity, except for the most
hydrophilic fraction no. 7 (SI=7) (Table II). n-BuOH
fractions showed no tumour-specific cytotoxicity (Table III).
Effect of SE and cholorophyllin on CYP3A activity. SE,
grapefruit juice and chlorophyllin dose-dependently inhibited
the CYP3A activity (hydroxylation activity of 6β-position of
testosterone), with 50% inhibitory concentration (IC50) being
0.99% (576 μg/ml), 0.49% and 109 μg/ml, respectively
(Figure 4). This indicates that CYP3A inhibitory activity of
SE is less than half of that of grapefruit juice and less than
1/5 of that of chlorophyllin.
Investigationf SE in healthy volunteers. Effect of oral
administration of SE on oral bacterial number was next
investigated (Figure 5). In the saliva, Porphyromonas
gingivalis was detected in volunteer C. Number of all
bacteria was decreased at day 7 after SE administration, and
thereafter increased up to day 28 in volunteer A. There was
no apparent change in the number of bacteria in volunteer B.
Number of bacteria declined until day 7, and gradually
returned to the initial level thereafter.
In the tongue coat, Porphyromonas gingivalis was
undetectable in all 3 volunteer. No apparent changes in the
number of bacteria were found in volunteer A. The number
of bacteria declined at day 21 in volunteer B. The number of
bacteria declined at day 3, and gradually returned to the
initial level thereafter in volunteer C.
In the periodontal pocket, the number of Prevotella and
Fusobacterium declined, but total number of anaerobic
bacteria did not change in volunteer A. The effect of SE was
not apparent in volunteer B. The number of total bacteria and
Fusobacterium declined in volunteer C.
Discussion
The present study demonstrated that SE did not inhibit the
production of TNF-α by LPS-activated macrophages, while
it inhibited their production of NO. This suggests the
different regulation between LPS-stimulation of TNF-α
production and that of NO production in macrophages. 
It was found that the majority of chlorophyllin and the
activity that inhibited the NO production by macrophages
was recovered from the water layer. This suggests the
possibility that chlorophyllin in SE may be associated with
hydrophilic substances, especially lignin-carbohydrate
complex in the native state or after extraction with alkaline
solution, since the preparative method of SE is the same with
that of lignin-carbohydrate complex (17). This was supported
in this study by the observation that lignin-carbohydrate
complex of SE has greenish color (absorption peak=655 nm),
characteristic to chlorophyllin (absorption peak=629 nm),
expected to contain 1.7-2.6% chlorophyllin in the molecule,
and that 68.5% of SE eluted as a single peak at the retention
time of 22.175 min in HPLC (Figure 6). Upon binding to
chlorophyllin, lignin-carbohydrate complex may obtain the
activity of inhibiting the NO production by activated
macrophages. It was also found that among seven n-BuOH
fractions, only no.7, that has the higher polarity, showed
some, but much lower anti-HIV activity (SI=7) than lignin-
carbohydrate complex (SI=27-62) (Table II). This suggests
that major anti-HIV activity of SE is exerted by lignin-
carbohydrate complex.
SE contains other bioactive phenolic compounds. 4’,5,7-
trihydroxy-3,5’-dimethoxylflavone (Tricin) from SE potently
inhibited the cytopathic effect of cytomegalovirus (18).
Apigenin 6-C-β-D-xylopyranosyl-8-C-β-D-glucopyranoside
(19), kurilensin A and B (20) in related Sasa plants scavenged
the 1,1-diphenyl-2-picrylhydrazyl (DPPH) radical. Tricin and
(–)-syringaresinol inhibited P-glycoprotein, thus enhancing
the cytotoxic activity of daunomycin against human breast
cancer cells (21). It is not clear to which extent these
compounds are responsible for total biological activity of SE.
The current preliminary experiment has shown that oral
administration of SE reduced the number of total bacteria,
Fusobacterium, and Prevotellain in volunteers A and C, but
not in subject B at day 7. This suggests that SE may exert
some anti-bacterial activity at early stage after SE
administration, although further clinical studies with more
numbers of subjects are necessary to confirm this possibility.
Stomatitis is generated in oral mucosa by various stimuli,
and aggravated by immunosuppression, and viral and bacterial
infections. Oral submucous fibrosis (OSF) is always associated
with a subepithelial inflammatory reaction followed by
fibroelastic changes of the lamina propria, accompanied by
epithelial atrophy (22). Currently, intralesional steroids,
hyaluronidase, micronutrients, minerals, carbon dioxide laser,
pentoxifylline, lycopene, immunised milk, interferon gamma,
turmeric, hyalase, chymotrypsin and collagenaseare are the
main treatment modalities (23). Mucositis (sore mouth)
induced by chemoradiotherapy via toxic free radicals is one
of the serious side effects of cancer therapy for oral cancer
(24). Recently, rebamipid (novel anti-ulcer drug) (25),
recombinant human epidermal growth factor (26) are used for
the treatment of mucositis. However, natural therapies that
have antiviral and antibacterial activity have not been applied
to stomatitis. SE is recognised as general drug that is effective
in treating stomatitis by the Ministry of Health, Labour and
Welfare, Japan, and its application as a preventiative and
therapeutic agent for stomatitis is therefore promising.
in vivo 24: 735-744 (2010)
742
The present study also revealed that SE inhibited CYP3A
activity to some extent. It is therefore important to monitor the
side effect of accompanying drug that is metabolised by CYP3A.
SE showed broad and potent anti-viral activity and
synergism with vitamin C (5). Since viral infection is one of
the major risk factors of oral cavity cancer (27), anti-viral
action of SE may reduce the incidence of virus-induced
carcinogenesis. These unique properties of SE suggest its
functionality as an alternative medicine.
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